Press release from Companies
Published: 2024-08-15 08:30:00
(Stockholm, 15 August 2024) Inhalation Sciences AB (ISAB) has received a surge of new orders, primarily for its Inhalation Research Services, as the summer season comes to a close and the company and wider inhalation industry gear up for a busy second half of the year.
The combined value of the new orders totals 50,000 Euro, or 600,000 SEK. The orders have been received from returning clients in ISAB’s extensive portfolio, primarily for CRO projects by its Inhaled Research Services team.
ISAB CEO Manoush Masarrat: "we are pleased to see clients hit the ground running again following the summer. We look forward to getting to work on the new projects and building on the momentum in coming months".
Explore Inhalation Research Services here.
For more information on Inhalation Sciences, please contact:
Manoush Masarrat, CEO
E-mail: Manoush.masarrat@inhalation.se
Mobile: +46 (0)73 628 9153
About Inhalations Sciences Sweden AB (publ)
Inhalation Sciences Sweden AB (publ) develops and commercializes world-leading instruments and services for research into inhalation. The company’s patented lab instruments PreciseInhale® and DissolvIt® enable researchers in the pharma industry to make drug pipeline decisions at an early stage, saving time and resources for R&D departments, and enables researchers in academic institutions to define how aerosols and small particles impact our lungs, whether new pollutants or life-saving drugs that power human development.
